The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-{[(4-chloro-1-guanidino-7-isoquinolinyl)sulphonyl]amino}cyclobutanecarboxylic acid ID: ALA228170
PubChem CID: 9930716
Max Phase: Preclinical
Molecular Formula: C15H16ClN5O4S
Molecular Weight: 397.84
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NC(N)=Nc1ncc(Cl)c2ccc(S(=O)(=O)NC3(C(=O)O)CCC3)cc12
Standard InChI: InChI=1S/C15H16ClN5O4S/c16-11-7-19-12(20-14(17)18)10-6-8(2-3-9(10)11)26(24,25)21-15(13(22)23)4-1-5-15/h2-3,6-7,21H,1,4-5H2,(H,22,23)(H4,17,18,19,20)
Standard InChI Key: DEPFCMSTRPLWNG-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
4.1568 -5.5112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7396 -4.9241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1526 -4.3412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5697 -4.9283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3039 -4.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3027 -5.1160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0171 -5.5287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0153 -3.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7301 -4.2856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7309 -5.1119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4457 -5.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1602 -5.1081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1555 -4.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4401 -3.8718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4474 -6.3470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1623 -6.7577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1640 -7.5821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8754 -6.3441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5884 -5.5278 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.8688 -5.9340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9969 -6.2439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1816 -4.8106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4409 -5.9203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7309 -5.5012 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4330 -6.7446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4358 -3.0468 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
6 7 1 0
13 14 2 0
14 9 1 0
7 10 2 0
11 15 1 0
3 4 1 0
15 16 2 0
9 8 2 0
16 17 1 0
8 5 1 0
16 18 1 0
4 1 1 0
6 19 1 0
19 20 1 0
9 10 1 0
19 21 2 0
1 2 1 0
19 22 2 0
10 11 1 0
20 1 1 0
5 6 2 0
1 23 1 0
11 12 2 0
23 24 1 0
2 3 1 0
23 25 2 0
14 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.84Molecular Weight (Monoisotopic): 397.0612AlogP: 1.08#Rotatable Bonds: 5Polar Surface Area: 160.76Molecular Species: ACIDHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 2.58CX Basic pKa: 8.01CX LogP: 0.21CX LogD: 0.12Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.43Np Likeness Score: -0.84
References 1. Fish PV, Barber CG, Brown DG, Butt R, Collis MG, Dickinson RP, Henry BT, Horne VA, Huggins JP, King E, O'Gara M, McCleverty D, McIntosh F, Phillips C, Webster R.. (2007) Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines., 50 (10): [PMID:17447747 ] [10.1021/jm061066t ]